Comparison of misoprostol and dinoprostone for elective induction of labour in nulliparous women at full term: a randomized prospective study
- PMID: 15450119
- PMCID: PMC524504
- DOI: 10.1186/1477-7827-2-70
Comparison of misoprostol and dinoprostone for elective induction of labour in nulliparous women at full term: a randomized prospective study
Abstract
Background: The objective of this randomized prospective study was to compare the efficacy of 50 mcg vaginal misoprostol and 3 mg dinoprostone, administered every nine hours for a maximum of three doses, for elective induction of labor in a specific cohort of nulliparous women with an unfavorable cervix and more than 40 weeks of gestation.
Material and methods: One hundred and sixty-three pregnant women with more than 285 days of gestation were recruited and analyzed. The main outcome measures were time from induction to delivery and incidence of vaginal delivery within 12 and 24 hours. Admission rate to the neonatal intensive care unit within 24 hours post delivery was a secondary outcome.
Results: The induction-delivery interval was significantly lower in the misoprostol group than in the dinoprostone group (11.9 h vs. 15.5 h, p < 0.001). With misoprostol, more women delivered within 12 hours (57.5% vs. 32.5%, p < 0.01) and 24 hours (98.7% vs. 91.4%, p < 0.05), spontaneous rupture of the membranes occurred more frequently (38.8% vs. 20.5%, p < 0.05), there was less need for oxytocin augmentation (65.8% vs. 81.5%, p < 0.05) and fewer additional doses were required (7.5% vs. 22%, p < 0.05). Although not statistically significant, a lower Caesarean section (CS) rate was observed with misoprostol (7.5% vs. 13.3%, p > 0.05) but with the disadvantage of higher abnormal fetal heart rate (FHR) tracings (22.5% vs. 12%, p > 0.05). From the misoprostol group more neonates were admitted to the intensive neonatal unit, than from the dinoprostone group (13.5% vs. 4.8%, p > 0.05). One woman had an unexplained stillbirth following the administration of one dose of dinoprostone.
Conclusions: Vaginal misoprostol, compared with dinoprostone in the regimens used, is more effective in elective inductions of labor beyond 40 weeks of gestation. Nevertheless, this is at the expense of more abnormal FHR tracings and more admissions to the neonatal unit, indicating that the faster approach is not necessarily the better approach to childbirth.
Similar articles
-
Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.Arch Gynecol Obstet. 2009 Jul;280(1):19-24. doi: 10.1007/s00404-008-0843-9. Epub 2008 Nov 26. Arch Gynecol Obstet. 2009. PMID: 19034471 Clinical Trial.
-
Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel.Br J Obstet Gynaecol. 1999 Aug;106(8):793-7. doi: 10.1111/j.1471-0528.1999.tb08399.x. Br J Obstet Gynaecol. 1999. PMID: 10453828 Clinical Trial.
-
A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction.Am J Obstet Gynecol. 1997 Sep;177(3):612-8. doi: 10.1016/s0002-9378(97)70154-6. Am J Obstet Gynecol. 1997. PMID: 9322632 Clinical Trial.
-
A randomised trial comparing low dose vaginal misoprostol and dinoprostone for labour induction.BJOG. 2004 Jan;111(1):42-9. doi: 10.1046/j.1471-0528.2003.00010.x. BJOG. 2004. PMID: 14687051 Clinical Trial.
-
Mechanical methods for induction of labour.Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4. Cochrane Database Syst Rev. 2023. PMID: 36996264 Free PMC article. Review.
Cited by
-
Results of Induction of Labor with Prostaglandins E1 and E2 (The RIPE Study): A Real-World Data Analysis of Obstetrical Effectiveness and Clinical Outcomes of Pharmacological Induction of Labor with Vaginal Inserts.Pharmaceuticals (Basel). 2023 Jul 8;16(7):982. doi: 10.3390/ph16070982. Pharmaceuticals (Basel). 2023. PMID: 37513894 Free PMC article.
-
Vaginal misoprostol for cervical ripening and induction of labour.Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD000941. doi: 10.1002/14651858.CD000941.pub2. Cochrane Database Syst Rev. 2010. PMID: 20927722 Free PMC article.
-
A Comparative Study of the Efficacy and Safety of Oral Misoprostol, Intravenous Oxytocin, and Intravaginal Dinoprostone for Labor Induction in Pakistani Women.Cureus. 2023 May 31;15(5):e39768. doi: 10.7759/cureus.39768. eCollection 2023 May. Cureus. 2023. PMID: 37398821 Free PMC article.
-
Comparative Study of Vaginal Misoprostol Tablet Versus Dinoprostone Insert in Induction of Labor: A Prospective Interventional Analysis.Cureus. 2025 Mar 4;17(3):e80026. doi: 10.7759/cureus.80026. eCollection 2025 Mar. Cureus. 2025. PMID: 40182360 Free PMC article.
-
The Impact of Maternal Obesity on the Duration of Labor Stages in Dinoprostone-Induced Vaginal Delivery.J Clin Med. 2025 May 6;14(9):3209. doi: 10.3390/jcm14093209. J Clin Med. 2025. PMID: 40364240 Free PMC article.
References
-
- Hilder L, Costeloe K, Thilaganathan B, Prolonged pregnancy. Evaluating gestation-specific risks of fetal and infant mortality. Br J Obstet Gynaecol. 1998;105:169–173. - PubMed
-
- Hannah ME, Hannah WJ, Hellmann J, Hewson S, Milner R, Willan A. Induction of labor as compared with serial antenatal monitoring in post term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group. N Engl J Med. 1992;326:1587–1592. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources